Proteomics and gene expression analyses of squalene-supplemented mice identify microsomal thioredoxin domain-containing protein 5 changes associated with hepatic steatosis

Journal of Proteomics

Volumn 77, Issue , 2012, Pages 27-39

  Ramírez Torres, Adela ^a   Barceló Batllori, Sílvia ^b   Martínez Beamonte, Roberto ^a,d   Navarro, María A ^c,d   Surra, Joaquín C ^a,d   Arnal, Carmen ^a,d   Guillén, Natalia ^a,d   Acín, Sergio ^c,d   Osada, Jesús ^a,d  

^a UNIVERSIDAD DE ZARAGOZA   (Spain)

^b INSTITUTO DE INVESTIGACIÓN SANITARIA ARAGÓN IIS ARAGÓN   (Spain)

^c HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^d Instituto de Salud Carlos III   (Spain)

Author keywords

ApoE knock out mice; Endoplasmic reticulum; Fatty liver; Proteomics; Squalene; TXNDC5

Indexed keywords

CARRIER PROTEIN; MESSENGER RNA; SQUALENE; THIOREDOXIN DOMAIN CONTAINING PROTEIN 5; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARG1 GENE; ARTICLE; ATP5B GENE; CAT GENE; CONTROLLED STUDY; DIET SUPPLEMENTATION; FAT CONTENT; FATTY LIVER; GENE; GENE EXPRESSION; HISTOPATHOLOGY; HYOU1 GENE; LIPID STORAGE; MALE; MOUSE; NIPSNAP1 GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATION REDUCTION STATE; PCCA GENE; PCX GENE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEOMICS; PYROXD2 GENE; RNA ANALYSIS;

ANIMALS; APOLIPOPROTEINS E; DIETARY SUPPLEMENTS; FATTY LIVER; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; LIPID METABOLISM; MALE; MICE; MICE, KNOCKOUT; MICROSOMES, LIVER; PROTEOMICS; RNA, MESSENGER; SQUALENE; THIOREDOXINS;

ANIMALIA; MUS;

EID: 84870394203     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2012.07.001     Document Type: Article

References (62)

1. Day C.P. Genetic and environmental susceptibility to non-alcoholic fatty liver disease. Dig Dis 2010, 28:255-260.
2. Kantartzis K., Schick F., Haring H.U., Stefan N. Environmental and genetic determinants of fatty liver in humans. Dig Dis 2010, 28:169-178.
3. Tiniakos D.G., Vos M.B., Brunt E.M. Nonalcoholic fatty liver disease: pathology and pathogenesis. Annu Rev Pathol 2010, 5:145-171.
4. Musso G., Gambino R., Cassader M. Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD). Prog Lipid Res 2009, 48:1-26.
5. Lou-Bonafonte J.M., Arnal C., Osada J. New genes involved in hepatic steatosis. Curr Opin Lipidol 2011, 22:159-164.
6. Acin S., Navarro M.A., Perona J.S., Surra J.C., Guillen N., Arnal C., et al. Microarray analysis of hepatic genes differentially expressed in the presence of the unsaponifiable fraction of olive oil in apolipoprotein E-deficient mice. Br J Nutr 2007, 97:628-638.
7. Assy N., Nassar F., Nasser G., Grosovski M. Olive oil consumption and non-alcoholic fatty liver disease. World J Gastroenterol 2009, 15:1809-1815.
8. Arbones-Mainar J.M., Ross K., Rucklidge G.J., Reid M., Duncan G., Arthur J.R., et al. Extra virgin olive oils increase hepatic fat accumulation and hepatic antioxidant protein levels in APOE-/- mice. J Proteome Res 2007, 6:4041-4054.
9. Covas M.I., Ruiz-Gutiérrez V., de la Torre R., Kafatos A., Lamuela-Raventós R.M., Osada J., et al. Minor components of olive oil: evidence to date of health benefits in humans. Nutr Rev 2006, 64:s20-s30.
10. Lou-Bonafonte J.M., Arnal C., Navarro M.A., Osada J. Efficacy of bioactive compounds from extra virgin olive oil to modulate atherosclerosis development. Mol Nutr Food Res 2012, 56:1043-1057.
11. Perona J.S., Cabello-Moruno R., Ruiz-Gutierrez V. The role of virgin olive oil components in the modulation of endothelial function. J Nutr Biochem 2006, 17:429-445.
12. Konstantinidou V., Covas M.I., Munoz-Aguayo D., Khymenets O., de la Torre R., Saez G., et al. In vivo nutrigenomic effects of virgin olive oil polyphenols within the frame of the Mediterranean diet: a randomized controlled trial. FASEB J 2010, 24:2546-2557.
13. Owen R.W., Mier W., Giacosa A., Hull W.E., Spiegelhalder B., Bartsch H. Phenolic compounds and squalene in olive oils: the concentration and antioxidant potential of total phenols, simple phenols, secoiridoids, lignans and squalene. Food Chem Toxicol 2000, 38:647-659.
14. Murkovic M., Lechner S., Pietzka A., Bratacos M., Katzogiannos E. Analysis of minor components in olive oil. J Biochem Biophys Methods 2004, 61:155-160.
15. Smith T.J. Squalene: potential chemopreventive agent. Expert Opin Investig Drugs 2000, 9:1841-1848.
16. Gylling H., Miettinen T.A. Postabsorptive metabolism of dietary squalene. Atherosclerosis 1994, 106:169-178.
17. Aguilera Y., Dorado M.E., Prada F.A., Martinez J.J., Quesada A., Ruiz-Gutierrez V. The protective role of squalene in alcohol damage in the chick embryo retina. Exp Eye Res 2005, 80:535-543.
18. Ramírez-Torres A., Gabás C., Barranquero C., Martínez- Beamonte R., Fernández-Juan M., Navarro M.A., et al. Squalene: Current Knowledge and Potential Therapeutical Uses 2010, NOVA, New York. First edition ed.
19. Guillen N., Acin S., Navarro M.A., Perona J.S., Arbones-Mainar J.M., Arnal C., et al. Squalene in a sex-dependent manner modulates atherosclerotic lesion which correlates with hepatic fat content in apoE-knockout male mice. Atherosclerosis 2008, 197:72-83.
20. Sarria A.J., Surra J.C., Acin S., Carnicer R., Navarro M.A., Arbones-Mainar J.M., et al. Understanding the role of dietary components on atherosclerosis using genetic engineered mouse models. Front Biosci 2006, 11:955-967.
21. Mensenkamp A.R., Van Luyn M.J., Havinga R., Teusink B., Waterman I.J., Mann C.J., et al. The transport of triglycerides through the secretory pathway of hepatocytes is impaired in apolipoprotein E deficient mice. J Hepatol 2004, 40:599-606.
22. Guillen N., Navarro M.A., Arnal C., Noone E., Arbones-Mainar J.M., Acin S., et al. Microarray analysis of hepatic gene expression identifies new genes involved in steatotic liver. Physiol Genomics 2009, 37:187-198.
23. Arbones-Mainar J.M., Navarro M.A., Guzman M.A., Arnal C., Surra J.C., Acin S., et al. Selective effect of conjugated linoleic acid isomers on atherosclerotic lesion development in apolipoprotein E knockout mice. Atherosclerosis 2006, 189:318-327.
24. Arbones-Mainar J.M., Navarro M.A., Acin S., Guzman M.A., Arnal C., Surra J.C., et al. Trans-10, cis-12- and cis-9, trans-11-conjugated linoleic acid isomers selectively modify HDL-apolipoprotein composition in apolipoprotein E knockout mice. J Nutr 2006, 136:353-359.
25. Hotamisligil G.S. Endoplasmic reticulum stress and atherosclerosis. Nat Med 2010, 16:396-399.
26. Cnop M., Foufelle F., Velloso L.A. Endoplasmic reticulum stress, obesity and diabetes. Trends Mol Med 2012, 18:59-68.
27. Fu S., Yang L., Li P., Hofmann O., Dicker L., Hide W., et al. Aberrant lipid metabolism disrupts calcium homeostasis causing liver endoplasmic reticulum stress in obesity. Nature 2011, 473:528-531.
28. Fu S., Watkins S.M., Hotamisligil G.S. The role of endoplasmic reticulum in hepatic lipid homeostasis and stress signaling. Cell Metab 2012, 15:623-634.
29. Osada J., Aylagas H., Sanchez-Prieto J., Sanchez-Vegazo I., Palacios-Alaiz E. Isolation of rat liver lysosomes by a single two-phase partition on dextran/polyethylene glycol. Anal Biochem 1990, 185:249-253.
30. Barcelo-Batllori S., Kalko S.G., Esteban Y., Moreno S., Carmona M.C., Gomis R. Integration of DIGE and bioinformatics analyses reveals a role of the antiobesity agent tungstate in redox and energy homeostasis pathways in brown adipose tissue. Mol Cell Proteomics 2008, 7:378-393.
31. Ramirez-Torres A., Barcelo-Batllori S., Fernandez-Vizarra E., Navarro M.A., Arnal C., Guillen N., et al. Proteomics and gene expression analyses of mitochondria from squalene-treated apoE-deficient mice identify short-chain specific acyl-CoA dehydrogenase changes associated with fatty liver amelioration. J Proteomics 2012, 75:2563-2575.
32. Bustin S.A. Why the need for qPCR publication guidelines?--The case for MIQE. Methods 2009/12/23, 217-226. [ed2010].
33. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
34. Surra J.C., Guillen N., Barranquero C., Arbones-Mainar J.M., Navarro M.A., Gascon S., et al. Sex-dependent effect of liver growth factor on atherosclerotic lesions and fatty liver disease in apolipoprotein E knockout mice. Histol Histopathol 2010, 25:609-618.
35. Mi H., Dong Q., Muruganujan A., Gaudet P., Lewis S., Thomas P.D. PANTHER version 7: improved phylogenetic trees, orthologs and collaboration with the Gene Ontology Consortium. Nucleic Acids Res 2009, 38:D204-D210.
36. Gygi S.P., Rochon Y., Franza B.R., Aebersold R. Correlation between protein and mRNA abundance in yeast. Mol Cell Biol 1999, 19:1720-1730.
37. Kim S.C., Sprung R., Chen Y., Xu Y., Ball H., Pei J., et al. Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. Mol Cell 2006, 23:607-618.
38. Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P. Large-scale phosphorylation analysis of mouse liver. Proc Natl Acad Sci U S A 2007, 104:1488-1493.
39. Saudek C.D., Frier B.M., Liu G.C. Plasma squalene: lipoprotein distribution and kinetic analysis. J Lipid Res 1978, 19:827-835.
40. De Roos B., Rucklidge G., Reid M., Pickard K., Navarro M.A., Arbonés-Mainar J.M., et al. Divergent mechanisms of cis9, trans11-and trans10, cis12-conjugated linoleic acid affecting insulin resistance and inflammation in apolipoprotein E knockout mice: a proteomics approach. FASEB J 2005, 19:1746-1748.
41. Afman L., Muller M. Nutrigenomics: from molecular nutrition to prevention of disease. J Am Diet Assoc 2006, 106:569-576.
42. Olofsson S.O., Boren J. Apolipoprotein B secretory regulation by degradation. Arterioscler Thromb Vasc Biol 2012, 32:1334-1338.
43. Fujimoto M., Hayashi T., Su T.P. The role of cholesterol in the association of endoplasmic reticulum membranes with mitochondria. Biochem Biophys Res Commun 2012, 417:635-639.
44. Kornmann B., Osman C., Walter P. The conserved GTPase Gem1 regulates endoplasmic reticulum-mitochondria connections. Proc Natl Acad Sci U S A 2011, 108:14151-14156.
45. Kim H.S., Kim J.M., Roh K.B., Lee H.H., Kim S.J., Shin Y.H., et al. Rat liver 10-formyltetrahydrofolate dehydrogenase, carbamoyl phosphate synthetase 1 and betaine homocysteine S-methytransferase were co-purified on Kunitz-type soybean trypsin inhibitor-coupled sepharose CL-4B. J Biochem Mol Biol 2007, 40:604-609.
46. Agrawal G., Joshi S., Subramani S. Cell-free sorting of peroxisomal membrane proteins from the endoplasmic reticulum. Proc Natl Acad Sci U S A 2011, 108:9113-9118.
47. Yonekawa S., Furuno A., Baba T., Fujiki Y., Ogasawara Y., Yamamoto A., et al. Sec16B is involved in the endoplasmic reticulum export of the peroxisomal membrane biogenesis factor peroxin 16 (Pex16) in mammalian cells. Proc Natl Acad Sci U S A 2011, 108:12746-12751.
48. Jessop C.E., Watkins R.H., Simmons J.J., Tasab M., Bulleid N.J. Protein disulphide isomerase family members show distinct substrate specificity: P5 is targeted to BiP client proteins. J Cell Sci 2009, 122:4287-4295.
49. Buddhan S., Sivakumar R., Dhandapani N., Ganesan B., Anandan R. Protective effect of dietary squalene supplementation on mitochondrial function in liver of aged rats. Prostaglandins Leukot Essent Fatty Acids 2007, 76:349-355.
50. Jiang X.C., Li Z., Liu R., Yang X.P., Pan M., Lagrost L., et al. Phospholipid transfer protein deficiency impairs apolipoprotein-B secretion from hepatocytes by stimulating a proteolytic pathway through a relative deficiency of vitamin E and an increase in intracellular oxidants. J Biol Chem 2005, 280:18336-18340.
51. Uchiyama S., Shimizu T., Shirasawa T. CuZn-SOD deficiency causes ApoB degradation and induces hepatic lipid accumulation by impaired lipoprotein secretion in mice. J Biol Chem 2006, 281:31713-31719.
52. Ni M., Lee A.S. ER chaperones in mammalian development and human diseases. FEBS Lett 2007, 581:3641-3651.
53. Flores-Diaz M., Higuita J.C., Florin I., Okada T., Pollesello P., Bergman T., et al. A cellular UDP-glucose deficiency causes overexpression of glucose/oxygen-regulated proteins independent of the endoplasmic reticulum stress elements. J Biol Chem 2004, 279:21724-21731.
54. Dhahbi J.M., Mote P.L., Tillman J.B., Walford R.L., Spindler S.R. Dietary energy tissue-specifically regulates endoplasmic reticulum chaperone gene expression in the liver of mice. J Nutr 1997, 127:1758-1764.
55. Nakatani Y., Kaneto H., Kawamori D., Yoshiuchi K., Hatazaki M., Matsuoka T.A., et al. Involvement of endoplasmic reticulum stress in insulin resistance and diabetes. J Biol Chem 2005, 280:847-851.
56. Wang Z.S., Lu F.E., Xu L.J., Dong H. Berberine reduces endoplasmic reticulum stress and improves insulin signal transduction in Hep G2 cells. Acta Pharmacol Sin 2010, 31:578-584.
57. Kobayashi T., Iguchi T., Ohta Y. Abetalipoproteinemia induced by overexpression of ORP150 in mice. Comp Med 2007, 57:247-254.
58. Wang Y., Wu Z., Li D., Wang D., Wang X., Feng X., et al. Involvement of oxygen-regulated protein 150 in AMP-activated protein kinase-mediated alleviation of lipid-induced endoplasmic reticulum stress. J Biol Chem 2011, 286:11119-11131.
59. Bloks V.W., Plosch T., van Goor H., Roelofsen H., Baller J., Havinga R., et al. Hyperlipidemia and atherosclerosis associated with liver disease in ferrochelatase-deficient mice. J Lipid Res 2001, 42:41-50.
60. Song S.H., Min B.I., Lee J.H., Cho K.S. Chronological effects of atherogenic diets on the aorta, liver and spleen of rabbits. J Korean Med Sci 2000, 15:413-419.
61. Brea A., Mosquera D., Martin E., Arizti A., Cordero J.L., Ros E. Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: a case-control study. Arterioscler Thromb Vasc Biol 2005, 25:1045-1050.
62. Spanova M., Zweytick D., Lohner K., Klug L., Leitner E., Hermetter A., et al. Influence of squalene on lipid particle/droplet and membrane organization in the yeast Saccharomyces cerevisiae. Biochim Biophys Acta 2012, 1821:647-653.